Scopus BioPharma Inc (SCPS)
0.0011
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Scopus BioPharma Total Assets (Quarterly): 0.4976M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.4976M |
| March 31, 2023 | 1.603M |
| December 31, 2022 | 0.3923M |
| September 30, 2022 | 0.4157M |
| June 30, 2022 | 1.673M |
| March 31, 2022 | 4.608M |
| December 31, 2021 | 8.188M |
| September 30, 2021 | 4.032M |
| Date | Value |
|---|---|
| June 30, 2021 | 6.808M |
| March 31, 2021 | 8.627M |
| December 31, 2020 | 1.974M |
| September 30, 2020 | 1.240M |
| December 31, 2019 | 0.7717M |
| June 30, 2019 | 1.478M |
| March 31, 2019 | 1.004M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.3923M
Minimum
Dec 2022
8.627M
Maximum
Mar 2021
3.022M
Average
1.638M
Median
Total Assets (Quarterly) Benchmarks
| Humanigen Inc | 5.116M |
| Cantabio Pharmaceuticals Inc | 0.3259M |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | 85.40M |
| Statera BioPharma Inc | 12.75M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.00M |
| Shareholders Equity (Quarterly) | -9.452M |